GlassScriptPhysician profile
Tse C Lee
NPI 1922259928
$10,353.21
in general payments reported to CMS, 2019-2025
34 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,681 · 2020: $1,764 · 2021: $1,634 · 2022: $1,255 · 2023: $1,103 · 2024: $1,001 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,019.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,619.92 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Medtronic USA, INC. | $2,646.58 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $986.72 | 2019-2023 | Relistor |
| Vertos Medical, INC. | $332.20 | 2019-2021 | |
| Allergan, INC. | $277.74 | 2019-2022 | |
| Boston Scientific Corporation | $170.14 | 2019-2022 | |
| Nevro Corp. | $165.61 | 2023-2024 | Senza |
| West Therapeutics Development, LLC | $158.05 | 2020-2021 | |
| Pfizer INC. | $157.92 | 2019-2020 | |
| Bioventus LLC | $149.12 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $136.57 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $126.27 | 2021-2023 | Ztlido |
| Redhill Biopharma INC. | $124.31 | 2020 | |
| Abbvie INC. | $116.30 | 2022-2023 | |
| Spr Therapeutics, INC | $109.67 | 2024-2025 | Sprint Pns System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $109.11 | 2019 | |
| Relievant Medsystems, INC. | $106.52 | 2022 | |
| Abbott Laboratories | $97.52 | 2019-2025 | Proclaim |
| Daiichi Sankyo INC. | $92.23 | 2019 | |
| Zyla Life Sciences, INC. | $84.43 | 2019-2020 | |
| Globus Medical, INC. | $78.64 | 2025 | Senza, Vyrsa V1 |
| Novartis Pharmaceuticals Corporation | $67.10 | 2019-2021 | |
| Saluda Medical Americas, INC. | $65.96 | 2025 | Evoke |
| Electronic Waveform Lab, INC. | $59.73 | 2025 | |
| Nalu Medical, INC. | $51.98 | 2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $50.46 | 2019-2025 | |
| Biodelivery Sciences International, INC. | $38.01 | 2021 | |
| Hikma Pharmaceuticals USA | $35.32 | 2022 | |
| Grt US Holding, INC. | $31.70 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $30.81 | 2020-2021 | |
| Smith+Nephew, INC. | $25.21 | 2019 | |
| Merz Pharmaceuticals, LLC | $23.69 | 2025 | Xeomin |
| Sonex Health, INC. | $16.02 | 2021 | |
| Painteq LLC | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tse Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.